These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25645331)

  • 1. Correcting for bias in the selection and validation of informative diagnostic tests.
    Robertson DS; Prevost AT; Bowden J
    Stat Med; 2015 Apr; 34(8):1417-37. PubMed ID: 25645331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bias in estimating accuracy of a binary screening test with differential disease verification.
    Alonzo TA; Brinton JT; Ringham BM; Glueck DH
    Stat Med; 2011 Jul; 30(15):1852-64. PubMed ID: 21495059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the estimation of the binomial probability in multistage clinical trials.
    Jung SH; Kim KM
    Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative double robust targeted maximum likelihood estimation.
    van der Laan MJ; Gruber S
    Int J Biostat; 2010 May; 6(1):Article 17. PubMed ID: 20628637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
    Di Stefano F; Pannaux M; Correges A; Galtier S; Robert V; Saint-Hilary G
    Stat Med; 2022 May; 41(10):1767-1779. PubMed ID: 35098579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility.
    Koopmeiners JS; Feng Z; Pepe MS
    Stat Med; 2012 Feb; 31(5):420-35. PubMed ID: 22238117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.
    Robertson DS; Prevost AT; Bowden J
    Stat Med; 2016 Sep; 35(22):3907-22. PubMed ID: 27103068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating misclassification error: a closer look at cross-validation based methods.
    Ounpraseuth S; Lensing SY; Spencer HJ; Kodell RL
    BMC Res Notes; 2012 Nov; 5():656. PubMed ID: 23190936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variance estimation and confidence intervals for the standardized mortality ratio with application to the assessment of a cancer screening program.
    Talbot D; Duchesne T; Brisson J; Vandal N
    Stat Med; 2011 Nov; 30(25):3024-37. PubMed ID: 22009761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements.
    Berglund L; Garmo H; Lindbäck J; Svärdsudd K; Zethelius B
    Stat Med; 2008 Sep; 27(22):4397-407. PubMed ID: 18618419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient regression calibration for logistic regression in main study/internal validation study designs with an imperfect reference instrument.
    Spiegelman D; Carroll RJ; Kipnis V
    Stat Med; 2001 Jan; 20(1):139-160. PubMed ID: 11135353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLDAssay: A software package and web tool for analyzing limiting dilution assays.
    Trumble IM; Allmon AG; Archin NM; Rigdon J; Francis O; Baldoni PL; Hudgens MG
    J Immunol Methods; 2017 Nov; 450():10-16. PubMed ID: 28733216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid report on estimating incidence from cross-sectional data.
    DeMonte JB; Neilan AM; Loop MS; Ciaranello AL; Hudgens MG
    Ann Epidemiol; 2021 Jan; 53():106-108.e1. PubMed ID: 32979470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What inference for two-stage phase II trials?
    Porcher R; Desseaux K
    BMC Med Res Methodol; 2012 Aug; 12():117. PubMed ID: 22867439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk assessment: Evaluation of screening tools for genetics referral.
    Himes DO; Zaro ML; Williams M; Freeborn D; Eggett DL; Kinney AY
    J Am Assoc Nurse Pract; 2019 Oct; 31(10):562-572. PubMed ID: 31425377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uniformly minimum variance unbiased estimation of gene diversity.
    Shete S
    J Hered; 2003; 94(5):421-4. PubMed ID: 14557396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.
    Zee J; Xie SX
    Biometrics; 2015 Sep; 71(3):772-81. PubMed ID: 25916510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correcting for selection bias in estimation of within-individual variance.
    Wilson PD
    Stat Med; 1988 Mar; 7(3):417-22. PubMed ID: 3358021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.